10.1177/20420188251383064 Ther Adv Endocrinol Metab
The treatment difference of 17.3 percentage points versus placebo represents the largest weight reduction achieved by any pharmacotherapy in a Phase 3 trial
Although several PPI inhibitors with improved selectivity have recently been identified, using combined approaches that brought together protein crystallography, ligand NMR spectroscopy, and computational chemistry, unfortunately, none of them has been found to be able to cross the BBB and many are quite large in size and contain carboxylic acids, features which usually prevent or decrease CNS permeability [299]
Some users have reported delays in medications and communication issues
Whether youre currently taking GLP-1s or considering them in your future, be sure to keep these biomarkers on your radar
Discuss your worries immediately with Dr